Robert G. Hughes

Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer

Hao Wang, S. Glavaris, E. Antonarakis, 2016, Cancer Chemotherapy and Pharmacology.